ABBOTT INDIA LIMITED Valuation
ABBOTINDIA · Healthcare · Current price ₹26,095
Is ABBOTT INDIA LIMITED undervalued?
DocStoX estimates the fair value of ABBOTT INDIA LIMITED at ₹15,107 per share, versus the current market price of ₹26,095. That puts the stock about -42.1% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 4 independent methods: Residual income (₹5,040), Relative P/E (₹25,725), Graham floor (₹6,076), Analyst target (₹33,792). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹5,040 (bear) to ₹15,107 (base) to ₹33,792 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Valuation multiples
ABBOTT INDIA LIMITED trades at a P/E of 35.7x and a P/B of 11.5x, with a dividend yield of 2.5%. Multiples are most useful compared against the company's own history and its sector peers — see the peer comparison for context.
Understand the ratios
More on ABBOTT INDIA LIMITED
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.